Back to search

Article

Preventing metastatic recurrence in low-risk ER/PR+ breast cancer patients – a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapy

2022-10-11

Abstract excerpt

<title>Abstract</title> <p><bold>Purpose:</bold> In the genomic era, more women with low-risk breast cancer will forego chemotherapy and rely on adjuvant endocrine therapy (AET) to prevent metastatic recurrence. However, some of these patients will unfortunately relapse. We sought to understand this outcome. Preliminary work suggested that early discontinuation of AET, also known as non-persistence, may play an i...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
8a196d61-84f8-5ef1-ada9-3c813d5822ac
DOI
10.21203/rs.3.rs-2085411/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Preventing metastatic recurrence in low-risk ER/PR+ breast cancer patients – a retrospective clinical study exploring the evolving challenge of persistence with adjuvant endocrine therapyDOI 10.21203/rs.3.rs-2085411/v1
Select a neighboring publication to make it the new centre.